Delivery Order SPE2DB22D2218-SPE2DB25FR2BU
Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml size. The contract, awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 28, 2025. The award has a ceiling value of $17,149.48 and is a firm fixed-price delivery order contract with a completion date of January 29, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,304.72 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024 with a completion date of November 1, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml Pen 2 ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,457.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 8, 2024, with a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,441.69 and a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen with a ceiling value of $35,108.30. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $9,195.61. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product Dupixent (300 mg/2 ml pen, 2 ml) to the Defense Logistics Agency (DLA). The fixed-price delivery order contract is valued at $11,130.10 and has an ultimate completion date of January 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,652.35 delivery order contract is for the supply of Dupixent 200 mg/1.14 ml pen medical products. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The single-award, indefinite delivery contract (IDC) has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical products...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,055.64, is a delivery order with a firm fixed price pricing type. It has an ultimate completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...